About HEPCINAT AND NATDAC TABLETS
Hepcinat And Natdac
Hepcinat + NatdacBrand Name: Hepcinat
- Content: Sofosbuvir
- Strength: 400mg
- Form : Tablets
- Packing: Pack of 28 tablets
- Uses : Treating chronic hepatitis C virus (HCV) infection in certain patient
- Manufactured by : Natco Pharma
Brand Name : Natdac
- Content : Daclatasvir Dihydrochloride
- Strengths : 60 mg
- Form : Tablets
- Packing : Pack of 28 Tablets
- Uses : Treating chronic hepatitis C virus (HCV) infection in certain patient
- Manufactured by : Natco Pharma
Note :- Hepcinat And Natdac Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............
Powerful Antiviral Therapy for Chronic Hepatitis CHEPCINAT and NATDAC Tablets are expertly formulated for treating chronic Hepatitis C infection in adults. Featuring the potent active ingredients Sofosbuvir and Daclatasvir, they target multiple HCV genotypes for broad-spectrum efficacy. With convenient once-daily dosing and robust USFDA-approved molecules, these medications bring effective viral suppression and improved clinical outcomes in eligible patients.
Reliable Packaging and Prescription SafetyBoth HEPCINAT and NATDAC tablets are supplied in HDPE bottles equipped with child-resistant caps, ensuring product integrity and safe storage. Each box contains a clear batch number and easy identification by colorlight blue for HEPCINAT, yellow for NATDAC. Available only via prescription, these medications guarantee regulated use under healthcare professional supervision.
Recommended Usage and Storage GuidelinesFor optimal effectiveness, patients should take one tablet daily at the same time, with or without food, as prescribed. Each tablet should be stored in its original HDPE bottle below 30C, protected from light and moisture. Always consult your healthcare provider for guidance on use, and never exceed the recommended dosage.
FAQs of HEPCINAT AND NATDAC TABLETS:
Q: How should I take HEPCINAT and NATDAC tablets for Hepatitis C treatment?
A: You should take one tablet of eachHEPCINAT (Sofosbuvir 400mg) and NATDAC (Daclatasvir 60mg)by mouth once daily, with or without food, at the same time each day. Always follow the dosing instructions provided by your healthcare provider.
Q: What are the main benefits of using HEPCINAT and NATDAC tablets?
A: These tablets combine two powerful USFDA-approved antiviral agents, providing effective therapy against chronic Hepatitis C virus of genotypes 1, 3, 4, 5, and 6. Their once-daily regimen enhances convenience and supports better treatment adherence.
Q: What potential side effects should I be aware of while taking these medications?
A: Common side effects may include fatigue, headache, and nausea. Always inform your doctor if you experience any persistent or severe symptoms during treatment.
Q: Where should I store HEPCINAT and NATDAC tablets?
A: Store the tablets in their original HDPE bottle below 30C, protected from light, moisture, and out of reach of children. Do not use the medication past the printed expiration or 24 months from manufacturing date.
Q: Who is eligible to use HEPCINAT and NATDAC tablets?
A: These medications are recommended for adult patients diagnosed with chronic Hepatitis C infection. They are available strictly by prescription from qualified healthcare professionals.
Q: When should I contact my healthcare provider during therapy?
A: Contact your healthcare provider if you experience severe side effects, notice an allergic reaction, or have concerns regarding medication adherence. Do not discontinue use without medical advice.